Chiltern closes its Theorem buy, doubling its workforce

U.K. CRO Chiltern has wrapped up its acquisition of former U.S. competitor Theorem Clinical Research, expanding its payroll and global reach in the process. Without disclosing financial terms, Chiltern said the integration gives it 3,700 employees in 47 countries, bringing in new clinical trial technologies the company believes will help it grow its client base. Release